Showing posts with label Skin Diseases Treatment Industry. Show all posts
Showing posts with label Skin Diseases Treatment Industry. Show all posts

What are the Latest Advancements in Skin Diseases Treatment Industry?

Skin Diseases Treatment Industry Data Book - Acne, Actinic Keratosis, Atopic Dermatitis, Alopecia Market Size, Share, Trends Analysis, and Segment Forecasts, 2023 - 2030

The global Skin Diseases Treatment Industry was estimated at USD 88.25 billion in 2022 and is anticipated to increase at a significant CAGR of 4.3% from 2022 to 2030.

Grand View Research’s skin diseases treatment industry data book is a collection of market sizing & forecasts insights, regulatory & technology framework, pricing intelligence, competitive benchmarking analyses, and macro-environmental analyses studies. Within the purview of the database, such information is systematically analyzed and provided in the form of summary presentations and detailed outlook reports on individual areas of research.

Actinic Keratosis Treatment Market Insights

The global actinic keratosis treatment market size was estimated at USD 6.42 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 4.20% from 2023 to 2030. The market is anticipated to witness growth opportunities owing to factors such as the rising prevalence of Actinic Keratosis (AK) and the wide presence and easy availability of generic drugs for its treatment. Moreover, the market is driven by increasing awareness about actinic keratosis and various strategic initiatives undertaken by industry players. Increasing consumer awareness regarding dermatological diseases, such as actinic keratosis, is a major growth booster for the market.

The increasing geriatric population across the globe is also anticipated to foster the growth of the market during the forecast period. According to America’s Health Rankings’ Senior Report 2021, it was estimated that more than 54 million adults aged over 65 live in the U.S. and their proportion in the total population accounted for 16.5%. Moreover, according to an article released by Statistics Canada in April 2022, more than 861,000 people in the country were aged 85 and above.

Moreover, actinic keratosis may lead to the development of squamous cell carcinoma, a type of skin cancer, which is expected to drive the actinic keratosis treatment market’s growth in the future. According to the Skin Cancer Foundation, anywhere between 40-60% of squamous cell carcinoma may start as an untreated precancerous lesion of actinic keratosis and 2-10% of cases may progress to Squamous cell carcinoma within the span of two years. This is likely to increase the adoption of the available treatment and early diagnosis of the disease.

Order your copy of the Free Sample of “Skin Diseases Treatment Industry Data Book - Acne, Actinic Keratosis, Atopic Dermatitis, Alopecia Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research

Alopecia Market Share by Treatment Type and Drug Segment 2022 (%)

Alopecia Market Insights

The global alopecia market was valued at USD 8.19 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 8.74% from 2023 to 2030. One of the major driving factors for the market is the increasing awareness regarding alopecia treatment options, as people are becoming more conscious of their appearance and actively seeking solutions to address hair loss.

Increasing prevalence of hair loss, technological advancements in alopecia treatment, and the rise in prevalence of chronic diseases that are associated with hair loss are some of the major factors driving the market growth globally. According to data published by the American Hair Loss Association, it was stated that over 95% of hair loss in men is caused due to androgenetic alopecia. Similarly, data published by the International Society of Hair Restoration Surgery, it was estimated that nearly 40% of men encounter some degree of hair loss by 35 years of age, 65% at 60 years, 70% at 80 years, and 80% at the age of 85.Owing to these factors, the androgenetic alopecia market size in terms of revenue is estimated to grow at a significant growth rate during the forecast period.

The growing prevalence of hair loss is one of the major factors driving the alopecia treatment market. According to data published by the Journal of Clinical and Diagnostic Research (JCDR), around 60% of the global population has hair thinning problems and pattern hair loss is the most common form of hair loss in both males and females. Moreover, around 2% of the global population is at risk of developing alopecia areata in their lifetime globally, irrespective of gender.

Go through the table of content of Skin Diseases Treatment Industry Data Book to get a better understanding of the Coverage & Scope of the study

Skin Diseases Treatment Industry Data Book Competitive Landscape

The presence of well-established companies in the skin diseases treatment market makes the entry of smaller players with newer products difficult. Companies are highly focused on R&D to develop and launch novel products that give them a competitive edge. Moreover, bigger players are aiming at acquiring smaller companies with upcoming promising products.

Key players operating in the Skin Diseases Treatment Industry are:

  • Pfizer Inc.
  • AbbVie Inc.
  • Sun Pharmaceutical Industries Ltd.
  • GSK plc.
  • Amgen Inc.

Check out more Industry Data Books, published by Grand View Research

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead. 

Contact:

Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com/sector-reports-list
Follow Us: LinkedIn | Twitter

Skin Diseases Treatment Industry: Atopic Dermatitis Market Size to grow at 8.70% CAGR by 2030

Skin Diseases Treatment Industry Data Book - Acne, Actinic Keratosis, Atopic Dermatitis, Alopecia Market Size, Share, Trends Analysis, and Segment Forecasts, 2023 - 2030

The economic value generated by the Skin Diseases Treatment industry was estimated at approximately USD 88.25 billion in 2022, and it is expanding at a CAGR of 4.3% from 2023 to 2030, according to a new report by Grand View Research, Inc.

Grand View Research’s skin diseases treatment industry data book is a collection of market sizing & forecasts insights, regulatory & technology framework, pricing intelligence, competitive benchmarking analyses, and macro-environmental analyses studies. Within the purview of the database, such information is systematically analyzed and provided in the form of summary presentations and detailed outlook reports on individual areas of research.

Access the Global Skin Diseases Treatment Industry Data Book, 2023 to 2030, compiled with details like market sizing information & forecasts, trade data, pricing intelligence, competitive benchmarking, macro-environmental analyses, and regulatory & technological framework studies

Actinic Keratosis Treatment Market Growth & Trends

The global actinic keratosis treatment market size is expected to reach USD 8.9 billion by 2030, registering a CAGR of 4.20% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is expected to witness growth opportunities owing to factors such as the wide availability of actinic keratosis therapeutics, rising awareness about the disease, and the rise in AK treatment. Moreover, the increasing prevalence of actinic keratosis and the rising geriatric population across the globe are expected to fuel the market growth during the forecast period.

Invasive squamous cell carcinoma may develop from AK when it becomes malignant (iSCC). Despite the fact that there are a number of potential causes for iSCC, AK is one of the most frequent ones. Additionally, basal cell carcinoma and non-melanoma skin cancer could result from AK. As a result, the demand for AK products across sales channels is being driven by the early diagnosis and treatment of actinic keratosis as a preventive strategy for comorbidities.

In addition, future pipeline medications and the increased use of combination therapy are key market drivers. For instance, Almirall, S.A. has Klisyri (extended label) in phase III of R&D. Furthermore, a rise in the acceptance and commercialization of innovative drugs is another factor that is predicted to fuel market growth. Moreover, increased R&D activities are expected to accelerate the approval of novel drugs used in the treatment of actinic keratosis, hence, propelling the growth over the forecast period.

U.S. Actinic Kertosis Treatment Market, Key Drug Class Segments and Trends (USD Million)

Order your copy of the Free Sample of “Skin Diseases Treatment Industry Data Book - Acne, Actinic Keratosis, Atopic Dermatitis, Alopecia Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research

Alopecia Market Growth & Trends

The global alopecia market size is expected to reach USD 16.02 billion by 2030, registering a CAGR of 8.74% from 2023 to 2030, according to a new report by Grand View Research, Inc. The approval of JAK inhibitors and tyrosine kinase inhibitors along with the rising target disease prevalence is expected to drive market growth.

The prevalence of alopecia areata (AA) and alopecia totalis is increasing globally. It is one of the most commonly encountered problems in clinics in the U.S. As per a research article published in March 2023, in the U.S. and UK, AA accounted for 0.6% to 2% of the new cases encountered in dermatology clinics. In hospital-based studies performed worldwide the incidence of AA is estimated to range between 0.57% to 3.8%.

The approval of new targeted pharmaceutical treatments is a key factor driving the alopecia market growth. For instance, in June 2022, the U.S. FDA approved Lilly’s Olumiant oral tablets for the treatment of severe alopecia in adult patients and is the first systemic treatment approved. Another key drug that is anticipated to be approved in 2023 is Pfizer’s Ritlecitinib. It is a dual inhibitor of Janus kinase 3 (JAK3) and tyrosine kinases.

Another key factor driving the industry’s growth is the increasing awareness regarding alopecia and thereby increasing treatment rates worldwide. The increase in the level of consciousness regarding physical appearance is one of the major reasons for the rising number of people seeking treatment. Additionally, rising investments in R&D and funding are also fueling market growth.

Go through the table of content of Skin Diseases Treatment Industry Data Book to get a better understanding of the Coverage & Scope of the study

Competitive Landscape

Key players operating in the Skin Diseases Treatment industry are:

  • Sun Pharmaceutical Industries Ltd.
  • Eli Lilly and Company
  • GSK plc
  • AstraZeneca
  • Teva Pharmaceutical Industries Ltd.

Check out more Industry Data Books, published by Grand View Research

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com/sector-reports-list
Follow Us: LinkedIn | Twitter

Skin Diseases Treatment Industry is driven by Rising Awareness Regarding Dermatology Diseases Drugs

Skin Diseases Treatment Industry Data Book - Acne, Actinic Keratosis, Atopic Dermatitis, Alopecia Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030

Grand View Research’s skin diseases treatment industry data book is a collection of market sizing & forecasts insights, regulatory & technology framework, pricing intelligence, competitive benchmarking analyses, and macro-environmental analyses studies. Within the purview of the database, such information is systematically analyzed and provided in the form of summary presentations and detailed outlook reports on individual areas of research. The following data points will be included in the final product offering in five reports and one sector report overview.

Access the Global Skin Diseases Treatment Industry Data Book, 2023 to 2030, compiled with details like trade data, pricing intelligence, and competitive benchmarking.

Actinic Keratosis Treatment Market Report Highlights

The global Actinic Keratosis Treatment Market size was estimated USD 6.42 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 4.20% from 2023 to 2030.

  • Surgery held the largest revenue share of 65.6% in 2022 owing to the rising adoption of cryotherapy surgery in the management of actinic keratosis
  • Nucleoside metabolic inhibitors held the largest revenue share of 32.4% in 2022 and is expected to retain its dominance over the forecast period
  • Asia Pacific is expected to grow at the fastest CAGR of 5.6% during the forecast period due to factors such as the high prevalence of AK, rapidly evolving healthcare infrastructure, and rising healthcare expenditures by Asia Pacific countries
  • North America dominated the market with the largest revenue share of 41.5% in 2022 due to the rising awareness among people about actinic keratosis, availability of robust treatment options, and improvements in healthcare infrastructure

Order your copy of Free Sample of “Skin Diseases Treatment Industry Data Book - Acne, Actinic Keratosis, Atopic Dermatitis, Alopecia Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research

Alopecia Market Share by Treatment Type and Drug Segment 2022 (%)

Alopecia Market Report Highlights

The global Alopecia Market size was estimated at USD 8.19 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 8.74% from 2023 to 2030.

  • In 2022, the AA segment dominated the alopecia industry with a revenue share of 35.13% and is anticipated to maintain its pole position throughout the forecast period
  • The alopecia universalis segment is expected to witness the fastest growth from 2023 to 2030, owing to the impending approval of pipeline products, such as Pfizer’s Ritlecitinib which is in the pre-registration phase, and Bioniz Therapeutics’s BNZ-1 which is in phase 2 clinical trials
  • North America dominated the market in 2022, mainly due to the high consumer awareness, technological advancements, high target disease population, and high healthcare spending
  • Asia Pacific is expected to grow at the highest CAGR during the forecast period. This can be majorly attributed to the rising target disease population and rising treatment rate for the disease
  • A few of the key market players include Janssen Global Services Inc.; Cipla Limited; Merck & Co., Inc.; GlaxoSmithKline plc; Sun Pharmaceuticals Industries Ltd.; Dr. Reddy’s Laboratories Ltd.; Aurobindo Pharma; Viatris Inc.

Go through the table of content of Skin Diseases Treatment Industry Data Book to get a better understanding of the Coverage and Scope of the study

Competitive Landscape

The presence of well-established companies in the skin diseases treatment market makes the entry of smaller players with newer products difficult. Companies are highly focused on R&D to develop and launch novel products that give them a competitive edge. Moreover, bigger players are aiming at acquiring smaller companies with upcoming promising products.

Key players operating in the Skin Diseases Treatment industry are:

  • Novartis AG
  • AbbVie, Inc.
  • Amgen Inc.
  • Johnson & Johnson Services Inc.
  • Leo Pharma A/S.

Check out more Industry Data Books, published by Grand View Research

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com/sector-reports-list
Follow Us: LinkedIn | Twitter

Inside the Crypto Wallet Market: Trends, Drivers, and Forecasts Through 2033

Crypto wallets have quietly become one of the most important pieces of infrastructure in the digital asset economy. Whether someone is tradi...